Reversal of low-grade cerebral edema after lactulose/rifaximin therapy in patients with cirrhosis and minimal hepatic encephalopathy

Clinical and Translational Gastroenterology

Volumn 6, Issue 9, 2015, Pages

  Rai, Rahul ^a   Ahuja, Chirag K ^a   Agrawal, Swastik ^a   Kalra, Naveen ^a   Duseja, Ajay ^a   Khandelwal, Niranjan ^a   Chawla, Yogesh ^a   Dhiman, Radha K ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

[No Author keywords available]

Indexed keywords

AMMONIA; INTERLEUKIN 1; INTERLEUKIN 6; LACTULOSE; RIFAXIMIN; TUMOR NECROSIS FACTOR;

ADULT; ARTICLE; BASAL GANGLION; BRAIN EDEMA; CAPSULA INTERNA; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FRONTAL WHITE MATTER; HEPATIC ENCEPHALOPATHY; HUMAN; LIVER CIRRHOSIS; MALE; NEUROPATHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PARIETAL WHITE MATTER; PRIORITY JOURNAL; PSYCHOMETRIC HEPATIC ENCEPHALOPATHY SCORE; SCORING SYSTEM; WHITE MATTER;

EID: 84989834213     PISSN: None     EISSN: 2155384X     Source Type: Journal    
DOI: 10.1038/ctg.2015.38     Document Type: Article

References (32)

1. Ferenci P, Lockwood A, Mullen K et al. Hepatic encephalopathy-definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998. Hepatology 2002; 35: 716-721.
2. Bajaj JS, Wade JB, Sanyal AJ. Spectrum of neurocognitive impairment in cirrhosis: Implications for the assessment of hepatic encephalopathy. Hepatology 2009; 50: 2014-2021.
3. Kale RA, Gupta RK, Saraswat VA et al. Demonstration of interstitial cerebral edema with diffusion tensor MR imaging in type C hepatic encephalopathy. Hepatology 2006; 43: 698-706.
4. Bosoi CR, Rose CF. Brain edema in acute liver failure and chronic liver disease: similarities and differences. Neurochem Int 2013; 62: 446-457.
5. Dhiman RK, Saraswat VA, Sharma BK et al. Minimal hepatic encephalopathy: consensus statement of a working party of the Indian National Association for Study of the Liver. J Gastroenterol Hepatol 2010; 25: 1029-1041.
6. Prasad S, Dhiman RK, Duseja A et al. Lactulose improves cognitive functions and healthrelated quality of life in patients with cirrhosis who have minimal hepatic encephalopathy. Hepatology 2007; 45: 549-559.
7. Amodio P, Del Piccolo F, Marchetti P et al. Clinical features and survivial of cirrhotic patients with subclinical cognitive alterations detected by the number connection test and computerized psychometric tests. Hepatology 1999; 29: 1662-1667.
8. Dhiman RK, Kurmi R, Thumburu KK et al. Diagnosis and prognostic significance of minimal hepatic encephalopathy in patients with cirrhosis of liver. Dig Dis Sci 2010; 55: 2381-2390.
9. Bajaj JS, Saeian K, Schubert CM et al. Minimal hepatic encephalopathy is associated with motor vehicle crashes: the reality beyond the driving test. Hepatology 2009; 50: 1175-1183.
10. Weissenborn K, Ennen JC, Schomerus H et al. Neuropsychological characterization of hepatic encephalopathy. J Hepatol 2001; 34: 768-773.
11. Chavarria L, Cordoba J. Magnetic resonance imaging and spectroscopy in hepatic encephalopathy. J Clin Exp Hepatol 2013; 5: S69-S74.
12. Aldridge DR, Tranaha EJ, Shawcross DL. Pathogenesis of hepatic encephalopathy: role of ammonia and systemic inflammation. J Clin Exp Hepatol 2014; 5: S7-S20.
13. Butterworth RF. Hepatic encephalopathy: a central neuroinflammatory disorder? Hepatology 2011; 53: 1372-1376.
14. Folstein MF, Robins LN, Helzer JE. The Mini-Mental State Examination. Arch Gen Psychiatry 1983; 40: 812.
15. Ortiz M, Cordoba J, Doval E et al. Development of a clinical hepatic encephalopathy staging scale. Aliment Pharmacol Ther 2007; 26: 859-867.
16. Dhiman RK, Saraswat VA, Verma M et al. Figure connection test: a universal test for assessment of mental state. J Gastroenterol Hepatol 1995; 10: 14-23.
17. Dhiman RK, Rana B, Agrawal S et al. Probiotic VSL#3 reduces liver disease severity and hospitalization in patients with cirrhosis: a randomized, controlled trial. Gastroenterology 147: 1327-1337. e3.
18. Ong JP, Aggarwal A, Krieger D et al. Correlation between ammonia levels and the severity of hepatic encephalopathy. Am J Med 2003; 114: 188-193.
19. Jain L, Sharma BC, Srivastava S et al. Serum endotoxin, inflammatory mediators, and magnetic resonance spectroscopy before and after treatment in patients with minimal hepatic encephalopathy. J Gastroenterol Hepatol 2013; 28: 1187-1193.
20. Shawcross DL, Sharifi Y, Canavan JB et al. Infection and systemic inflammation, not ammonia, are associated with grade 3/4 hepatic encephalopathy, but not mortality in cirrhosis. J Hepatol 2011; 54: 640-649.
21. Shawcross DL, Wright G, Olde Damink SW et al. Role of ammonia and inflammation in minimal hepatic encephalopathy. Metab Brain Dis 2007; 22: 125-138.
22. Montoliu C, Piedrafita B, Serra MA et al. IL-6 and IL-18 in blood may discriminate cirrhotic patients with and without minimal hepatic encephalopathy. J Clin Gastroenterol 2009; 43: 272-279.
23. Butterworth RF. The liver-brain axis in liver failure: neuroinflammation and encephalopathy. Nat Rev Gastroenterol Hepatol 2013; 10: 522-528.
24. Das K, Singh P, Chawla Y et al. Magnetic resonance imaging of brain in patients with cirrhotic and non-cirrhotic portal hypertension. Dig Dis Sci 2008; 53: 2793-2798.
25. Cordoba J, Sanpedro F, Alonso J et al. 1H magnetic resonance in the study of hepatic encephalopathy in humans. Metab Brain Dis 2002; 17: 415-429.
26. Thuluvath PJ, Edwin D, Yue NC et al. Increased signals seen in globus pallidus in T1-weighted magnetic resonance imaging in cirrhotics are not suggestive of chronic hepatic encephalopathy. Hepatology 1995; 21: 440-442.
27. Iwasa M, Kinosada Y, Nakatsuka A et al. Magnetization transfer contrast of various regions of the brain in liver cirrhosis. AJNR Am J Neuroradiol 1999; 20: 652-654.
28. Rovira A, Grive E, Pedraza S et al. Magnetization transfer ratio values and proton MR spectroscopy of normal-Appearing cerebral white matter in patients with liver cirrhosis. AJNR Am J Neuroradiol 2001; 22: 1137-1142.
29. Miese FR, Wittsack HJ, Kircheis G et al. Voxel-based analyses of magnetization transfer imaging of the brain in hepatic encephalopathy. World J Gastroenterol 2009; 15: 5157-5164.
30. Cordoba J, Alonso J, Rovira A et al. The development of low-grade cerebral edema in cirrhosis is supported by the evolution of (1)H-magnetic resonance abnormalities after liver transplantation. J Hepatol 2001; 35: 598-604.
31. Sugimoto R, Iwasa M, Maeda M et al. Value of the apparent diffusion coefficient for quantification of low-grade hepatic encephalopathy. Am J Gastroenterol 2008; 103: 1413-1420.
32. Weissenborn K, Ahl B, Fischer-Wasels D et al. Correlations between magnetic resonance spectroscopy alterations and cerebral ammonia and glucose metabolism in cirrhotic patients with and without hepatic encephalopathy. Gut 2007; 56: 1736-1742.